News & Updates

New drug applications approved by US FDA as of 16-28 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Awareness about human papillomavirus (HPV) infection in males and the benefits of vaccination on both genders is low among young adults, reveals a Singapore study.

For women using contraceptives while on psychotropic drugs, the risk of adverse events appears to be lower with drospirenone than with levonorgestrel, whereas contraceptive failure is uncommon across progestins, according to a real-world study.

Blood pressure (BP) estimates in pregnant women of the mobile app OptiBP meet the AAMI/ESH/ISO 81060-2:2018 criteria and are on a par with that of an oscillometric device, reports a study.

New drug applications approved by US FDA as of 1-15 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Treatment with palbociclib plus exemestane with ovarian function suppression does not appear to produce improvements in overall survival (OS), although it yields sustained increases in progression-free survival (PFS) as compared with capecitabine in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer, according to updated data from the phase II Young-PEARL study.

Conception via assisted reproductive technology (ART) carries an increased risk of foetal malformation among women with epilepsy, according to a study.

Disordered eating, along with consumption of certain food items, may predispose middle-aged women to pelvic floor disorders, as suggested in a study.

Climacteric women with eating disorders are more likely to exhibit night eating habits and experience more severe symptoms of menopause, as reported in a descriptive study.

Individuals with nonmalignant gynaecological diseases appear to be at increased risk of cardiovascular and cerebrovascular diseases, according to the results of a systematic review and meta-analysis.